Most Claims In Amiodarone Death Case Dismissed With Leave To Refile
FRESNO, Calif. — A California federal judge on Feb. 14 dismissed various claims against Pfizer Inc. and Mylan Institutional Inc. in a wrongful death case involving the anti-arrhythmia heart drug amiodarone...To view the full article, register now.
Already a subscriber? Click here to view full article